A safe therapeutic apheresis protocol in paediatric patients weighing 11 to 25 kg

Vox Sanguinis

Volumn 107, Issue 4, 2014, Pages 375-380

  Maitta, R W ^a,b   Vasovic, L V ^c,d   Mohandas, K ^c,d   Music Aplenc, L ^e   Bonzon Adelson, A ^c   Uehlinger, J ^c,d  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MONTEFIORE MEDICAL CENTER   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e CHILDREN S MERCY HOSPITAL   (United States)

Author keywords

Anticoagulant citrate dextrose A; Erythrocytapheresis; Leukapheresis; Paediatric

Indexed keywords

ACID CITRATE DEXTROSE; ALLOANTIBODY; DIPHENHYDRAMINE; HEMOGLOBIN; HEMOGLOBIN A; IBUPROFEN; ANTICOAGULANT AGENT;

ACUTE LEUKEMIA; APHERESIS; APHERESIS DEVICE; ARTICLE; BLOOD TRANSFUSION REACTION; CHILD; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; ERYTHROCYTAPHERESIS; FEMALE; HEMATOCRIT; HUMAN; HYPOCALCEMIA; LEUKAPHERESIS; LEUKOCYTE COUNT; LEUKOSTASIS; MALE; PEDIATRIC INTENSIVE CARE UNIT; SICKLE CELL ANEMIA; SICKLE CELL BETA THALASSEMIA; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; ACUTE DISEASE; ADVERSE EFFECTS; ANEMIA, SICKLE CELL; BLOOD; BLOOD CLOTTING; BODY WEIGHT; COHORT ANALYSIS; DRUG EFFECTS; INFANT; INTENSIVE CARE UNIT; LEUKEMIA; PRESCHOOL CHILD;

ACUTE DISEASE; ANEMIA, SICKLE CELL; ANTICOAGULANTS; BLOOD COAGULATION; BLOOD COMPONENT REMOVAL; BODY WEIGHT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HEMATOCRIT; HEMOGLOBIN A; HUMANS; INFANT; INTENSIVE CARE UNITS; ISOANTIBODIES; LEUKEMIA; LEUKOCYTE COUNT; LEUKOSTASIS; MALE;

EID: 84912017235     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12164     Document Type: Article

References (32)

1. Gorlin JB: Therapeutic plasma exchange and cytapheresis in pediatric patients. Transfus Sci 1999; 21:21-39
2. Kirkham FJ, DeBaun MR: Stroke in children with sickle cell disease. Curr Treat Options Neurol 2004; 6:357-375
3. Danielson CF: The role of red blood cell exchange transfusion in the treatment and prevention of complications of sickle cell disease. Ther Apher 2002; 6:24-31
4. Maurer HS, Steinherz PG, Gaynon PS, et al.: The effect of initial management of hyperleukocytosis on early complications and outcome of children with acute lymphoblastic leukemia. J Clin Oncol 1988; 6:1425-1432
5. Zarkovic M, Kwaan HC: Correction of hyperviscosity by apheresis. Semin Thromb Hemost 2003; 29:535-542
6. Blum W, Porcu P: Therapeutic apheresis in hyperleukocytosis and hyperviscosity syndrome. Semin Thromb Hemost 2007; 33:350-354
7. Kara A, Turgut S, Cagli A, et al.: Complications of therapeutic apheresis in children. Transfus Apher Sci 2013; 48:375-376
8. Kevy SV, Fosburg M: Therapeutic apheresis in childhood. J Clin Apher 1990; 5:87-90
9. Stefanutti C, Lanti A, Di Giacomo S, et al.: Therapeutic apheresis in low weight patients: technical feasibility, tolerance, compliance, and risks. Transfus Apher Sci 2004; 31:3-10
10. Sauer H, Roland H, Ulla L, et al.: Leukapheresis in children weighing less than 20 kg. Pediatr Blood Cancer 2012; 58:627-629
11. Worel N, Peteres C, Gerhartl K, et al.: Collection of peripheral blood stem cells (PBSC) after chemotherapy and administration of rhGM-CSF in children weighing less than 17 kg. Transfus Sci 1996; 17:601-606
12. Okamoto Y, Watanabe T, Watanabe H, et al.: Double apheresis of peripheral blood stem cells in a single day in children mobilized by granulocyte colony-stimulating factor for transplantation. Pediatr Transplant 2009; 13:440-443
13. Pulsipher MA, Levine JE, Hayashi RJ, et al.: Safety and efficacy of allogeneic PBSC collection in normal pediatric donors: the pediatric blood and marrow transplant consortium experience (PBMTC) 1996-2003. Bone Marrow Transplant 2005; 35:361-367
14. Orbach D, Hojjat-Assari S, Doz F, et al.: Peripheral blood stem cell collection in 24 low-weight infants: experience of a single centre. Bone Marrow Transplant 2003; 31:171-174
15. Schwartz J, Winters JL, Padmanabhan A, et al.: Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue. J Clin Apher 2013; 28:145-284
16. Donaldson JS: Pediatric vascular access. Pediatr Radiol 2006; 36:386-397
17. Nathan D, Orkin S: Nathan and Oski's Hematology of Infancy and Childhood, 5th edn. Philadelphia, WB Saunders, 1998
18. McLeod BC, Kim HC: Therapeutic Apheresis. San Diego, Elsevier, Inc., 2004
19. Rogers RL, Cooling LLW: Therapeutic apheresis in pediatric patients; in: McLeod BC, Price TH, Weinstein R (eds): Apheresis: Principles and Practice. Bethesda, AABB Press, 2003:477-492
20. Winters JL, Gottschall JL: Therapeutic Apheresis: A Physician's Handbook, 3rd edn. Bethesda, AABB Press, 2011
21. Girard J, Tremisi PJ, Kassir A, et al.: Apheresis tolerance and acceptability in the child weighing 30 kg or less, with the exception of infants. Transfus Clin Biol 1996; 3:297-304
22. Hulbert ML, Scothorn DJ, Panepinto JA, et al.: Exchange blood transfusion compared with simple transfusion for first overt stroke is associated with a lower risk of subsequent stroke: a retrospective cohort study of 137 children with sickle cell anemia. J Pediatr 2006; 149:710-712
23. Pociello N, Corrales E, Jordan I, et al.: Large volume leukapheresis with the Cobe Spectra AutoPBSC in a 7-kg child. J Pediatr Hematol Oncol 2007; 29:862
24. Cecyn KZ, Seber A, Ginani VC, et al.: Large-volume leukapheresis for peripheral blood progenitor cell collection in low body weight pediatric patients: a single center experience. Transfus Apher Sci 2005; 32:269-274
25. Masera N, Tavecchia L, Pozzi L, et al.: Periodic erythroexchange is an effective strategy for high risk paediatric patients with sickle-cell disease. Transfus Apher Sci 2007; 37:241-247
26. Takaue Y, Kawano Y, Abe T, et al.: Collection and transplantation of peripheral blood stem cells in very small children weighting 20 kg or less. Blood 1995; 86:372-380
27. Cabibbo S, Fidone C, Garozzo G, et al.: Chronic red blood cell exchange to prevent clinical complications in sickle cell disease. Transfus Apher Sci 2005; 32:315-321
28. Bolan CD, Yau YY, Cullis HC, et al.: Pediatric large-volume leukapheresis: a single institution experience with heparin versus citrate-based anticoagulant regimens. Transfusion 2004; 44:229-238
29. Michon B, Moghrabi A, Winikoff R, et al.: Complications of apheresis in children. Transfusion 2007; 47:1837-1842
30. Kim HC: Therapeutic pediatric apheresis. J Clin Apher 2000; 15:129-157
31. Hunt EA, Jain NG, Somers MJ: Apheresis therapy in children: an overview of key technical aspects and a review of experience in pediatric renal disease. J Clin Apher 2013; 28:36-47
32. Wong EC, Balogun RA: Therapeutic apheresis in pediatrics: technique adjustments, indications and nonindications, a plasma exchange focus. J Clin Apher 2012; 27:132-137